The Current Status – And Future Prospects – Of This COVID-19 Vaccine Partnership
In March, two small biotechs partnered to develop a vaccine for COVID-19 using a mechanism called RNA interference (RNAi) – and early data for the…
In March, two small biotechs partnered to develop a vaccine for COVID-19 using a mechanism called RNA interference (RNAi) – and early data for the…
The biotech stock highlighted in today’s article is already up 173% so far this year, and now the author advises that “a historically bullish signal…
The biotech company highlighted in today’s article, specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer, is one that…
“Although the vast majority of biotech stocks are losing money, a handful of these profitable drug developers are valued at levels that make them absolute…
“Biotech stocks are breaking out,” declares the author of today’s article. When it comes to playing this breakout, however, he advises that the obvious play…
“Both of these biotechs deserve a lot more attention than they’ve been receiving,” asserts the author of today’s article in regards to two clinical-stage biotech…
Drugs for pain management, migraines, dry eye disease and Ebola are among those with PDUFA dates – deadlines by which the FDA must review new…
Product candidates for the treatment of excessive underarm sweating on one hand, and dry eye disease on the other, could help the two stocks highlighted…
What does the most recent data indicate about short interest in the top biotech stocks? The short answer, today’s article notes, is that “short interest…
“Call it what you will, but I think traders who’ve dug into the biotech space initially came for the COVID, then figured out there’s far…